TY - JOUR A1 - Wenzel, Mike A1 - Yu, Hang A1 - Uhlig, Annemarie A1 - Würnschimmel, Christoph A1 - Wallbach, Manuel A1 - Becker, Andreas A1 - Fisch, Margit A1 - Chun, Felix A1 - Meyer, Christian P. A1 - Leitsmann, Marianne T1 - Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy T2 - International urology and nephrology N2 - Purpose: To test the value of preoperative and postoperative cystatin C (CysC) as a predictor on kidney function after partial (PN) or radical nephrectomy (RN) in renal cell carcinoma (RCC) patients with normal preoperative renal function. Methods: From 01/2011 to 12/2014, 195 consecutive RCC patients with a preoperative estimated glomerular filtration rate (eGFR) > 60 ml/min/1.73m2 underwent surgical RCC treatment with either PN or RN. Logistic and linear regression models tested for the effect of CysC as a predictor of new-onset chronic kidney disease in follow-up (eGFR < 60 ml/min/1.73m2). Moreover, postoperative CysC and creatinine values were compared for kidney function estimation. Results: Of 195 patients, 129 (66.2%) underwent PN. In postoperative and in follow-up setting (median 14 months, IQR 10–20), rates of eGFR < 60 ml/min/1.73m2 were 55.9 and 30.2%. In multivariable logistic regression models, preoperative CysC [odds ratio (OR): 18.3] and RN (OR: 13.5) were independent predictors for a reduced eGFR < 60 ml/min/1.73m2 in follow-up (both p < 0.01), while creatinine was not. In multivariable linear regression models, a difference of the preoperative CysC level of 0.1 mg/dl estimated an eGFR decline in follow-up of about 5.8 ml/min/1.73m2. Finally, we observed a plateau of postoperative creatinine values in the range of 1.2–1.3 mg/dl, when graphically depicted vs. postoperative CysC values (‘creatinine blind area’). Conclusion: Preoperative CysC predicts renal function impairment following RCC surgery. Furthermore, CysC might be superior to creatinine for renal function monitoring in the early postoperative setting. KW - Cystatin C KW - Nephrectomy KW - Renal cell carcinoma KW - GFR KW - Acute kidney injury Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63702 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-637023 SN - 1573-2584 N1 - Open Access funding enabled and organized by Projekt DEAL. VL - 53 IS - 10 SP - 2041 EP - 2049 PB - Springer Science + Business Media B.V. CY - Dordrecht [u.a.] ER -